EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Atopic dermatitis: treatment and innovations in immunotherapy

Francesco Ferrara, Andrea Zovi, Maurizio Capuozzo, Roberto Langella

Inflammopharmacology · 2024

DOI: 10.1007/s10787-024-01453-8 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Inflammopharmacology, 2024. Verfasst von Francesco Ferrara und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Department, Asl Napoli 3 Sud, Dell'Amicizia Street, 22, 80035, Nola, Naples, Italy. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Immunotherapy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD) is a common inflammatory skin disease characterized by itching and skin barrier dysfunction. Moderate to severe AD is often refractory to first-line topical treatments, and systemic immunosuppressants have been shown to be effective but have significant adverse effects. The paucity of basic treatments has contributed to the development of targeted topical and systemic immunotherapies based on the use of small molecules and biologic drugs which can directly interact with AD pathogenetic pathways. They represent a new era of therapeutic innovation. Additional new treatments are desirable since AD is a heterogeneous disease marked by different immunological phenotypes. This manuscript will review the mechanism of action, safety profile, and efficacy of promising new systemic immunological treatments for AD. Since moderate to severe AD can result in poor quality of life, the development of targeted and well-tolerated immunomodulators is a crucial purpose. The introduction of new pharmacological agents may offer new therapeutic options. However, there is the need to evaluate how "narrow-acting" agents, such as individual interleukin inhibitors, will perform under the safety and efficacy profiles compared with "broad-acting" agents, such as JAK inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicImmunotherapyHumansAnimalsQuality of LifeImmunosuppressive AgentsImmunologic Factors

Stichwörter der Autor:innen

Atopic dermatitisImmunomodulatorsImmunotherapyInterleukin inhibitorsJAK inhibitors

Substanzen

Immunosuppressive AgentsImmunologic Factors

Autor:innen und Institutionen

  • Pharmaceutical Department, Asl Napoli 3 Sud, Dell'Amicizia Street, 22, 80035, Nola, Naples, Italy.
  • Ministry of Health, Viale Giorgio Ribotta, 5, 00144, Rome, Italy. zovi.andrea@gmail.com.
  • Pharmaceutical Department, Asl Napoli 3 Sud, Marittima Street, 3, 80056, Ercolano, Naples, Italy.
  • Italian Society of Hospital Pharmacy (SIFO), SIFO Secretariat of the Lombardy Region, Via Carlo Farini, 81, 20159, Milan, Italy.

Zitieren

APA

Ferrara, F., Zovi, A., Capuozzo, M., & Langella, R. (2024). Atopic dermatitis: treatment and innovations in immunotherapy. Inflammopharmacology. https://doi.org/10.1007/s10787-024-01453-8

Vancouver

Ferrara F, Zovi A, Capuozzo M, Langella R. Atopic dermatitis: treatment and innovations in immunotherapy. Inflammopharmacology. 2024. doi:10.1007/s10787-024-01453-8

BibTeX
@article{Ferrara2024,
  author = {Ferrara, Francesco and Zovi, Andrea and Capuozzo, Maurizio and Langella, Roberto},
  title = {Atopic dermatitis: treatment and innovations in immunotherapy},
  journal = {Inflammopharmacology},
  year = {2024},
  doi = {10.1007/s10787-024-01453-8}
}
Kostenlos starten →